These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 25204479

  • 1. Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris.
    Esmaili N, Chams-Davatchi C, Valikhani M, Daneshpazhooh M, Toosi S, Karimi A, Mortazavi H.
    Arch Iran Med; 2014 Sep; 17(9):626-8. PubMed ID: 25204479
    [Abstract] [Full Text] [Related]

  • 2. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
    Chams-Davatchi C, Esmaili N, Daneshpazhooh M, Valikhani M, Balighi K, Hallaji Z, Barzegari M, Akhyani M, Ghodsi SZ, Seirafi H, Nazemi MJ, Mortazavi H, Mirshams-Shahshahani M.
    J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373
    [Abstract] [Full Text] [Related]

  • 3. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
    Esmaili N, Chams-Davatchi C, Valikhani M, Farshidfar F, Parvaneh N, Tamizifar B.
    Eur J Dermatol; 2008 Oct; 18(2):159-64. PubMed ID: 18424375
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M, Kolacinska-Strasz Z, Sulej J, Labecka H, Cwikla J, Natorska U, Blaszczyk M.
    Am J Clin Dermatol; 2007 Oct; 8(2):85-92. PubMed ID: 17428113
    [Abstract] [Full Text] [Related]

  • 5. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
    Mentink LF, Mackenzie MW, Tóth GG, Laseur M, Lambert FP, Veeger NJ, Cianchini G, Pavlovic MD, Jonkman MF.
    Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
    [Abstract] [Full Text] [Related]

  • 6. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
    España Alonso A, Panizo C, Fernández S, Marquina M, Pretel M, Aguado L, Sánchez-Ibarrola A.
    Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
    [Abstract] [Full Text] [Related]

  • 7. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
    Beissert S, Werfel T, Frieling U, Böhm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Luger TA.
    Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
    [Abstract] [Full Text] [Related]

  • 8. [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris].
    Chams-Davatchi C, Nonahal Azar R, Daneshpazooh M, Valikhani M, Hallaji Z, Barzegari M, Firouz AR, Zakeri M.
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):23-5. PubMed ID: 11937925
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris.
    Sharma VK, Khandpur S.
    Clin Exp Dermatol; 2013 Aug; 38(6):659-64. PubMed ID: 23837939
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate is effective in the treatment of pemphigus vulgaris.
    Enk AH, Knop J.
    Arch Dermatol; 1999 Jan; 135(1):54-6. PubMed ID: 9923781
    [Abstract] [Full Text] [Related]

  • 11. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
    Kim MR, Kim HC, Kim SC.
    Dermatology; 2011 Jan; 223(2):182-8. PubMed ID: 22025028
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil as adjuvant in pemphigus vulgaris.
    Sarma N, Ghosh S.
    Indian J Dermatol Venereol Leprol; 2007 Jan; 73(5):348-50. PubMed ID: 17921620
    [Abstract] [Full Text] [Related]

  • 13. Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial.
    Dastgheib L, Sadati MS, Baghernejhad M.
    J Dermatolog Treat; 2015 Feb; 26(1):90-3. PubMed ID: 24552352
    [Abstract] [Full Text] [Related]

  • 14. Outcome of pemphigus vulgaris.
    Kavusi S, Daneshpazhooh M, Farahani F, Abedini R, Lajevardi V, Chams-Davatchi C.
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):580-4. PubMed ID: 18194237
    [Abstract] [Full Text] [Related]

  • 15. Treatment outcomes in a cohort of patients with mucosal-predominant pemphigus vulgaris.
    Ojaimi S, O'Connor K, Lin MW, Schifter M, Fulcher DA.
    Intern Med J; 2015 Mar; 45(3):284-92. PubMed ID: 25534017
    [Abstract] [Full Text] [Related]

  • 16. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus.
    Saha M, Powell AM, Bhogal B, Black MM, Groves RW.
    Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532
    [Abstract] [Full Text] [Related]

  • 17. Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris.
    Chams-Davatchi C, Mortazavizadeh A, Daneshpazhooh M, Davatchi F, Balighi K, Esmaili N, Akhyani M, Hallaji Z, Seirafi H, Mortazavi H.
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1285-92. PubMed ID: 23062214
    [Abstract] [Full Text] [Related]

  • 18. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study.
    Rose E, Wever S, Zilliken D, Linse R, Haustein UF, Bröcker EB.
    J Dtsch Dermatol Ges; 2005 Mar; 3(3):200-6. PubMed ID: 16372814
    [Abstract] [Full Text] [Related]

  • 19. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C, Ligtenberg G, Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
    [Abstract] [Full Text] [Related]

  • 20. Recalcitrant pemphigus vulgaris responding to systemic tacrolimus.
    Büsing V, Kern JS, Bruckner-Tuderman L, Hofmann SC.
    Dermatology; 2010 Aug; 221(2):122-6. PubMed ID: 20587990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.